# US Medical Aesthetics Market

> US Medical Aesthetics Market Research Report: Size, Share, Trend Analysis By Product (Facial Aesthetic Products, Cosmetics Implant, Skin Aesthetic Devices, Body Contouring Devices, Physician-dispensed Cosmeceuticals and Skin Lighteners, Hair Removal Devices, Tattoo Removal Devices, Thread Lift Products, Physician-dispensed Eyelash Products, and Nail Treatment Laser Devices), By Procedure (Surgical Procedures (Breast Augmentation, Rhinoplasty, Facelift and Body Lift, Other Surgical Procedures), and Non-Surgical Procedures (Anti-Aging and Skin Rejuvenation, Tattoo and Scar Removal, Hair Removal, Lipolysis, and Other Non-Surgical Procedures), By End Users (Clinics, Hospitals, and Medical Spas, Beauty Centers, and Home Care Settings) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 8.51%
- **2024:** $ 5.5 Billion
- **2025:** $ 5.97 Billion
- **2035:** $ 13.5 Billion
- **Key Players:** Allergan (US), Galderma (CH), Revance Therapeutics (US), Medytox (KR) (remove duplicate), Hugel (KR), Ipsen (FR), Medytox (KR), Sientra (US), Hugel (KR)

**Report ID:** MRFR/MED/11121-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-medical-aesthetics-market-12644

---

## Market Summary

## **US Medical Aesthetics Market Overview**

US Medical Aesthetics Market Size was valued at USD 2.5 Billion in 2022. The US Medical Aesthetics Market industry is projected to grow from USD 2.71 Billion in 2023 to USD 5.209 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.50% during the forecast period (2023 - 2032). The market drivers boosting the growth of the market include the increasing use of non-invasive and minimally invasive aesthetic operations, increased consumer knowledge of cosmetic products, and an increase in the use of aesthetic procedures by the elderly population to enhance their appearance.

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

## **US Medical Aesthetics Market Trends**

### **Increase in the popularity of non-invasive and minimally invasive cosmetic procedures is driving the market growth**

Cosmetic medicine is seeing an increase in minimally invasive and non-surgical aesthetic procedures, which provide a practical and less dangerous substitute for conventional surgery. These procedures, which include chemical peels, microdermabrasion, laser therapy, dermal fillers, and Botox, address a variety of aesthetic issues with outcomes that seem natural. Their simplicity in recuperation and easy resumption of everyday activities stems from their minimal downtime. Furthermore, their adaptability and configurable features are making them more and more popular with people of all ages.

For example, the Plastic Surgery Statistics Report 2020 from the American Society of Plastic Surgeons states that 6.8 million reconstructive treatments, 13.2 million cosmetic minimally invasive procedures, and 2.3 million cosmetic surgical procedures were carried out in the US in 2020. Significantly, these therapies reduce scarring, which makes them the therapy of choice for people who are worried about surgical scars. For safe and successful results, nevertheless, only licensed medical professionals should carry out these procedures, and for individualized treatment regimens, communication with healthcare providers is essential.

Plastic surgery, breast implants, injection therapy for botulinum toxin, and other anti-aging goods and treatments have been made possible by technological advancements and large investments in research and development. The potential for growth in the anti-aging market has been increased by producers introducing safer and more effective treatments due to strict rules and regulations. Furthermore, specialized businesses have made high-end anti-aging products more accessible and available, despite the fact that department stores have always carried them. These days, these goods are sold through speciality retail stores, infomercials, home shopping channels, salons, spas, and internet sellers.

Thus, driving the US Medical Aesthetics Market revenue.

## **US Medical Aesthetics Market Segment Insights**

### **US Medical Aesthetics Product Insights**

The US Medical Aesthetics Market segmentation, based on product includes Facial Aesthetic Products, Cosmetics Implant, Skin Aesthetic Devices, Body Contouring Devices, Physician-dispensed Cosmeceuticals and Skin Lighteners, [Hair Removal Devices](../../../reports/hair-removal-devices-market-7323), Tattoo Removal Devices, Thread Lift Products, Physical-Dispensed Eyelash Products, and Nail Treatment Laser Devices. The facial aesthetic products segment dominated the market mostly because more and more women are choosing to work, having more money to spend, and wanting to look young, attractive, and get the best possible treatment.

Additionally, the segment's growth is expected to be influenced by the growing demand for derma filers because of their advantageous applications, which include reducing the look of sunken scars, softening facial creases and wrinkles, boosting shallow contours, and plumping thin lips.

### **US Medical Aesthetics Procedure Insights**

The US Medical Aesthetics Market segmentation, based on procedure, includes Surgical Procedures (Breast Augmentation, Rhinoplasty, Facelift and Body Lift, Other Surgical Procedures), and Non-Surgical Procedures (Anti-Aging and Skin Rejuvenation, Tattoo and Scar Removal, Hair Removal, Lipolysis, and Other Non-Surgical Procedures. The non-surgical procedures category generated the most income. Some of the elements that have increased demand for non-invasive procedures include less pain, quick outcomes, and low cost. Nutraceuticals, soft tissue fillers, and chemical peels are popular non-invasive procedures.

### **US Medical Aesthetics End User Insights**

The US Medical Aesthetics Market segmentation, based on end user, includes Clinics, Hospitals, and Medical Spas, Beauty Centers, and Home Care Settings. The clinics, hospitals, and medical spas category generated the most income because of a variety of factors, including the easier availability to material and financial resources at clinics and hospitals, including skilled surgeons and more. Furthermore, developments in medical aesthetic procedures are readily available and deliverable in hospitals and clinics, which supports segment expansion.

**Figure 1: US Medical Aesthetics Market, by End User, 2022 & 2032 (USD Billion)**

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

### **United States US Medical Aesthetics Market Regional Insights**

The US Medical Aesthetics Market area will grow at a significant rate as a result of the large number of cosmetic procedures carried out, the aging population, more disposable income, greater awareness, and government support for the infrastructure of healthcare. The region's robust research pipeline, the development of high-tech products, and the FDA's approval of aesthetic devices for home use are all contributing factors to the growing demand for US Medical Aesthetics. Additionally, a variety of market participants in this nation contribute to the industry's growth.

The market is expected to grow even faster as long as major players in the country continue to meet the high and rising demand.

## **US Medical Aesthetics Key Market Players & Competitive Insights**

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the US Medical Aesthetics Market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their  footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, US Medical Aesthetics industry must offer cost-effective items.

### **Key Companies in the US Medical Aesthetics Market include**

- AbbVie
- [Cynosure](https://aestheticsbycynosure.com/)
- Evolus Inc.
- Revance Therapeutics, Inc
- Galderma
- [Lumenis](https://lumenis.com/aesthetics/homepage/)
- Solta Medical
- Syneron Candela
- Alma Laser

## **US Medical Aesthetics Market Segmentation**

### **US Medical Aesthetics Product Outlook**

- Facial Aesthetic Products
- Cosmetics Implant
- Skin Aesthetic Devices
- Body Contouring Devices
- Physician-dispensed Cosmeceuticals and Skin Lighteners
- Hair Removal Devices
- Tattoo Removal Devices
- Thread Lift Products
- Physician-dispensed Eyelash Products
- Nail Treatment Laser Devices

### **US Medical Aesthetics Procedure Outlook**

### **US Medical Aesthetics End User Outlook**

- Clinics, Hospitals, and Medical Spas
- Beauty Centers
- Home Care Settings

### US Medical Aesthetics Market Industry Developments

- **Q2 2024: Allergan Aesthetics Announces FDA Approval of Skinvive™ by JUVÉDERM® for the Improvement of Cheek Skin Smoothness in Adults** Allergan Aesthetics, an AbbVie company, received FDA approval for Skinvive™ by JUVÉDERM®, a hyaluronic acid intradermal microdroplet injection, for improving cheek skin smoothness in adults.
- **Q2 2024: Crown Aesthetics Announces FDA Clearance of SkinPen® Precision for the Treatment of Neck Wrinkles** Crown Aesthetics received FDA clearance for its SkinPen® Precision microneedling device to treat neck wrinkles, expanding its indications beyond facial acne scars.
- **Q2 2024: Soliton Announces FDA Clearance of Rapid Acoustic Pulse Device for Cellulite Reduction** Soliton, Inc. received FDA clearance for its Rapid Acoustic Pulse device, designed for the reduction in the appearance of cellulite, marking a new product entry in the U.S. medical aesthetics market.
- **Q3 2024: Alma Lasers Launches Alma TED™ Hair Restoration System in the United States** Alma Lasers announced the U.S. launch of Alma TED™, a non-invasive ultrasound-based system for hair restoration, expanding its portfolio of energy-based aesthetic devices.
- **Q3 2024: Galderma Announces U.S. Launch of Restylane® Eyelight™ for the Treatment of Undereye Hollows** Galderma launched Restylane® Eyelight™ in the U.S., a hyaluronic acid dermal filler specifically indicated for the treatment of undereye hollows.
- **Q3 2024: Sientra Files for Chapter 11 Bankruptcy Protection** Sientra, a U.S. medical aesthetics company specializing in breast implants and body contouring, filed for Chapter 11 bankruptcy protection as it seeks to restructure its operations.
- **Q4 2024: Revance Therapeutics Announces FDA Approval of DAXXIFY® for the Treatment of Cervical Dystonia** Revance Therapeutics received FDA approval for DAXXIFY® (daxibotulinumtoxinA-lanm) for the treatment of cervical dystonia, expanding its therapeutic indications in the U.S. market.
- **Q4 2024: Merz Aesthetics Launches Radiesse® (+) Lidocaine for Hand Augmentation in the U.S.** Merz Aesthetics announced the U.S. launch of Radiesse® (+) Lidocaine, a dermal filler for hand augmentation to correct volume loss in the dorsum of the hands.
- **Q1 2025: Cutera Appoints New CEO to Lead Next Phase of Growth** Cutera, a provider of energy-based aesthetic systems, appointed a new Chief Executive Officer to drive the company’s strategic growth initiatives in the U.S. medical aesthetics sector.
- **Q1 2025: Venus Concept Announces U.S. Launch of Venus Bliss Max™ for Non-Invasive Body Contouring** Venus Concept launched Venus Bliss Max™ in the U.S., a new non-invasive device for body contouring and fat reduction, expanding its product offerings in the medical aesthetics market.
- **Q2 2025: Almirall Completes Acquisition of Bonti, Expanding U.S. Aesthetics Portfolio** Almirall completed the acquisition of Bonti, a U.S.-based company focused on fast-acting neurotoxin treatments, strengthening its position in the U.S. medical aesthetics market.
- **Q2 2025: Cynosure Announces Opening of New U.S. Manufacturing Facility for Aesthetic Devices** Cynosure opened a new manufacturing facility in the United States to increase production capacity for its portfolio of energy-based aesthetic devices.

## Market Drivers

### Advancements in Treatment Technologies

Technological innovations are transforming the medical aesthetics market, enhancing the efficacy and safety of various procedures. New devices and techniques, such as laser technologies and advanced injectables, are being developed, offering improved results with reduced downtime. For instance, the introduction of non-invasive body contouring technologies has gained traction, appealing to consumers seeking effective solutions without surgical intervention. As these advancements continue to emerge, they are expected to attract a broader audience, including those who may have previously been hesitant to undergo aesthetic treatments. The medical aesthetics market is thus positioned for growth, driven by the continuous evolution of treatment technologies.

### Growing Demand for Aesthetic Treatments

The medical aesthetics market is experiencing a notable increase in demand for aesthetic treatments, driven by a rising societal emphasis on physical appearance. This trend is particularly evident among younger demographics, who are increasingly seeking non-invasive procedures to enhance their looks. According to recent data, the market is projected to grow at a CAGR of approximately 10% over the next five years. This growth is fueled by the desire for quick recovery times and minimal discomfort associated with non-surgical options. As more individuals prioritize self-care and personal grooming, the medical aesthetics market is likely to expand, catering to a diverse clientele seeking various treatments, from injectables to skin rejuvenation therapies.

### Increased Accessibility of Aesthetic Services

The medical aesthetics market is witnessing increased accessibility to aesthetic services, which is likely to drive market growth. The expansion of clinics and treatment centers across urban and suburban areas has made aesthetic procedures more available to a wider audience. Additionally, competitive pricing strategies and financing options are making treatments more affordable for consumers. This trend is particularly relevant as more individuals seek to invest in their appearance, leading to a rise in the number of procedures performed annually. As accessibility improves, the medical aesthetics market is expected to flourish, catering to a diverse range of clients seeking various aesthetic enhancements.

### Influence of Social Media and Celebrity Culture

The medical aesthetics market is significantly influenced by social media platforms and celebrity endorsements, which play a crucial role in shaping public perceptions of beauty. The proliferation of platforms such as Instagram and TikTok has created a culture where aesthetic enhancements are not only normalized but celebrated. Influencers and celebrities often share their experiences with aesthetic procedures, leading to increased interest and inquiries among their followers. This trend appears to be driving a surge in demand for treatments, as individuals aspire to achieve similar looks. Consequently, the medical aesthetics market is likely to see continued growth as social media continues to shape beauty standards and consumer behavior.

### Rising Awareness of Mental Health and Self-Image

The medical aesthetics market is increasingly intersecting with the growing awareness of mental health and self-image. As individuals recognize the impact of physical appearance on self-esteem and overall well-being, there is a heightened interest in aesthetic treatments as a means of enhancing self-confidence. This trend is particularly pronounced among younger generations, who are more open to discussing mental health issues and the role of aesthetics in personal satisfaction. The medical aesthetics market is likely to benefit from this shift, as more individuals seek treatments that align with their desire for improved self-image and mental wellness.

## Future Outlook

The medical aesthetics market is projected to grow at 8.51% CAGR from 2025 to 2035, driven by technological advancements, increasing consumer awareness, and rising disposable incomes.

**New opportunities:**

- Expansion of telemedicine consultations for aesthetic procedures. Development of personalized skincare products using AI technology. Investment in minimally invasive treatment options to attract younger demographics.

By 2035, the medical aesthetics market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Product: Facial Aesthetic (Largest) vs. Body Contouring Devices (Fastest-Growing)

The market share distribution among the segment values reveals that Facial Aesthetic holds the largest share, driven by a strong consumer preference for facial rejuvenation procedures. Following closely, Body Contouring Devices are gaining traction as demand for non-invasive body shaping solutions surges. Other categories such as Cosmetic Implants, Hair Removal Devices, and Skin Aesthetic Devices also contribute to the market, yet they trail behind these leading segments. Growth trends in the US medical aesthetics market show a significant shift towards minimally invasive procedures, with consumers increasingly seeking effective solutions that require less downtime. The rise of social media and celebrity endorsements has catalyzed interest in aesthetic enhancements, particularly in facial treatments. Additionally, advancements in technology and the introduction of innovative products are propelling the Body Contouring Devices segment as a fast-growing area, attracting investment and consumer attention alike.

Facial Aesthetic (Dominant) vs. Body Contouring Devices (Emerging)

Facial Aesthetic remains the dominant segment in the US medical aesthetics market, characterized by a broad array of treatments such as Botox, dermal fillers, and laser resurfacing. This segment benefits from a well-established consumer base, growing awareness, and evolving treatment options that cater to diverse needs. In contrast, Body Contouring Devices have emerged as a pivotal segment, leveraging innovative technologies like cryolipolysis and radiofrequency to offer non-surgical fat reduction solutions. With increasing public interest in body sculpting and weight management, this segment is witnessing robust demand and rapid development, indicating a promising future trajectory as consumers seek effective, non-invasive methods for achieving their aesthetic goals.

### By Technology: Non-Invasive (Largest) vs. Minimally Invasive (Fastest-Growing)

The market share distribution among the segment values in the US medical aesthetics market shows a strong prominence of Non-Invasive technologies, which capture the largest share due to their appeal to a broader audience seeking less risky procedures. Minimally Invasive techniques are also gaining traction, marking a notable percentage of the overall market as patients opt for solutions that balance effectiveness with reduced recovery times. This segmentation highlights the industry's shift towards more accessible treatment options. Growth trends within this segment are largely driven by rising consumer demand for safer, quicker, and less invasive aesthetic solutions. Factors such as improved technology, innovative product offerings, and increasing preferences for enhanced personal appearance accelerate the adoption of Minimally Invasive techniques, positioning them as a vital growth area in the market. Furthermore, media influence and celebrity endorsements contribute significantly to the acceptance and popularity of these technologies among consumers.

Invasive: Surgical Procedures (Dominant) vs. Minimally Invasive: Injectables (Emerging)

Invasive surgical procedures hold a dominant position in the US medical aesthetics market, characterized by their efficacy in delivering long-lasting results for significant aesthetic changes. Despite being associated with higher risks and longer recovery times, they remain popular among individuals seeking dramatic transformations. In contrast, Minimally Invasive injectables are emerging rapidly, appealing to a younger demographic favoring convenience and quicker results with minimal downtime. The increasing variety of available injectables, coupled with growing marketing efforts, contributes to their emerging status. This dynamic showcases the ongoing evolution of patient preferences, driving continued innovation across both segments.

### By End-Use: Hospitals & Clinics (Largest) vs. Dermatology & Cosmetic Centers (Fastest-Growing)

In the US medical aesthetics market, Hospitals & Clinics hold the largest share, showcasing their robust infrastructure and diverse service offerings that cater to a wide range of patient needs. These facilities are equipped with advanced technologies, making them a preferred choice among consumers seeking comprehensive aesthetic solutions. In contrast, Dermatology & Cosmetic Centers are gaining ground, rapidly increasing their market presence driven by the rising demand for specialized skin and beauty treatments. The growth trends in these segments are fueled by several factors, including increasing awareness of aesthetic procedures and a shift towards non-invasive treatments. Hospitals & Clinics continue to dominate due to their extensive resources and holistic approach, while Dermatology & Cosmetic Centers are emerging as a favored option for targeted aesthetic services, appealing to younger demographics prioritizing cosmetic enhancements. This dynamic landscape highlights a competitive marketplace where both segments play crucial roles in meeting consumer demands.

Hospitals & Clinics (Dominant) vs. Dermatology & Cosmetic Centers (Emerging)

Hospitals & Clinics are characterized by their comprehensive service offerings and access to cutting-edge medical technologies, establishing their dominance in the US medical aesthetics market. These facilities not only provide aesthetic treatments but also integrate them with medical services such as reconstructive surgeries, thus appealing to a broader patient demographic. Conversely, Dermatology & Cosmetic Centers are rapidly emerging as key players, focusing specifically on cosmetic enhancements and aesthetic procedures. Their specialized services, often set in more personal and private environments, attract clients seeking advanced skin care treatments. This segmentation allows these centers to cater to specific consumer needs, capitalizing on the growing market trend towards individualized aesthetic services.

## Regional Market Share Analysis

### North America : Market Leader in Aesthetics

The North American medical aesthetics market is driven by increasing consumer demand for non-invasive procedures, technological advancements, and a growing aging population. The U.S. holds the largest market share at approximately 70%, followed by Canada at around 15%. Regulatory support from agencies like the FDA further propels market growth, ensuring safety and efficacy in aesthetic treatments. The U.S. is home to key players such as Allergan, Revance Therapeutics, and Galderma, which dominate the competitive landscape. The presence of advanced healthcare infrastructure and high disposable income levels contribute to the region's attractiveness. Additionally, the rise of social media influences consumer choices, leading to increased awareness and acceptance of aesthetic procedures, further solidifying North America's leading position in the market.

### Europe : Emerging Market Dynamics

The European medical aesthetics market is characterized by a growing demand for minimally invasive procedures and a rising focus on personal appearance. Germany and the UK are the largest markets, holding approximately 25% and 20% of the market share, respectively. Regulatory frameworks, such as the EU Medical Device Regulation, are pivotal in ensuring product safety and efficacy, fostering consumer trust and market growth. Leading countries like France and Italy are also witnessing significant growth, driven by increasing disposable incomes and a cultural emphasis on beauty. The competitive landscape features key players like Galderma and Ipsen, which are expanding their product offerings. The region's diverse consumer base and innovative marketing strategies are enhancing the appeal of aesthetic treatments, making Europe a dynamic player in the global market.

### Asia-Pacific : Rapid Growth Potential

The Asia-Pacific medical aesthetics market is experiencing rapid growth, driven by rising disposable incomes, increasing awareness of aesthetic procedures, and a growing middle-class population. China and Japan are the largest markets, accounting for approximately 30% and 20% of the market share, respectively. Regulatory bodies are increasingly focusing on safety standards, which is expected to enhance consumer confidence and drive market expansion. Countries like South Korea are also emerging as significant players, known for their innovative aesthetic technologies and trends. The competitive landscape includes local and international companies, with key players like Medytox and Hugel leading the charge. The region's unique beauty standards and cultural acceptance of aesthetic procedures are further fueling demand, positioning Asia-Pacific as a burgeoning market in the global landscape.

### Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa medical aesthetics market is gradually evolving, driven by increasing urbanization, rising disposable incomes, and a growing interest in cosmetic procedures. The UAE and South Africa are the largest markets, holding approximately 25% and 15% of the market share, respectively. Regulatory frameworks are being developed to ensure safety and efficacy, which is crucial for market growth and consumer trust. Countries like Saudi Arabia are witnessing a surge in demand for aesthetic treatments, supported by a young population and increasing social acceptance. The competitive landscape is characterized by both local and international players, with companies like Sientra gaining traction. The region's unique cultural dynamics and increasing focus on personal appearance are expected to drive further growth in the medical aesthetics market.

## Competitive Benchmarking

The medical aesthetics market is characterized by a dynamic competitive landscape, driven by innovation, consumer demand for non-invasive procedures, and an increasing focus on personalized treatments. Key players such as Allergan (US), Galderma (CH), and Revance Therapeutics (US) are at the forefront, each employing distinct strategies to enhance their market presence. Allergan (US) continues to leverage its strong brand recognition and extensive product portfolio, focusing on expanding its offerings in injectables and skin care. Galderma (CH) emphasizes its commitment to research and development, aiming to introduce novel solutions that cater to evolving consumer preferences. Revance Therapeutics (US) is notable for its innovative approach, particularly with its DaxibotulinumtoxinA injection, which aims to provide longer-lasting results, thereby positioning itself as a leader in the competitive landscape. In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market appears moderately fragmented, with several players vying for market share, yet the collective influence of major companies shapes competitive dynamics significantly. This fragmentation allows for niche players to emerge, while larger firms consolidate their positions through strategic partnerships and acquisitions.
In October Allergan (US) announced a strategic partnership with a leading telehealth platform to enhance patient access to aesthetic consultations. This move is likely to expand its customer base by integrating digital solutions into traditional aesthetic practices, thereby aligning with the growing trend of telemedicine. Such initiatives may not only improve patient engagement but also streamline service delivery, reflecting a broader shift towards digital transformation in the industry.
In September Revance Therapeutics (US) launched a new marketing campaign aimed at educating consumers about the benefits of its innovative DaxibotulinumtoxinA product. This campaign is significant as it seeks to differentiate Revance's offerings in a crowded market, potentially increasing brand loyalty and consumer trust. By focusing on education, Revance may enhance its competitive edge, appealing to a more informed consumer base that values transparency and efficacy.
In August Galderma (CH) expanded its product line with the introduction of a new range of skin care products designed specifically for post-procedure care. This strategic move indicates Galderma's commitment to holistic patient care, potentially increasing customer retention and satisfaction. By addressing the needs of patients beyond the initial treatment, Galderma may strengthen its market position and foster long-term relationships with consumers.
As of November current trends in the medical aesthetics market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence in treatment planning and patient engagement. Strategic alliances are increasingly shaping the competitive landscape, allowing companies to pool resources and expertise. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift suggests that companies that prioritize these areas may gain a substantial advantage in an ever-evolving market.

## Recent News & Developments

- **Q2 2024: Allergan Aesthetics Announces FDA Approval of Skinvive™ by JUVÉDERM® for the Improvement of Cheek Skin Smoothness in Adults** Allergan Aesthetics, an AbbVie company, received FDA approval for Skinvive™ by JUVÉDERM®, a hyaluronic acid intradermal microdroplet injection, for improving cheek skin smoothness in adults.
- **Q2 2024: Crown Aesthetics Announces FDA Clearance of SkinPen® Precision for the Treatment of Neck Wrinkles** Crown Aesthetics received FDA clearance for its SkinPen® Precision microneedling device to treat neck wrinkles, expanding its indications beyond facial acne scars.
- **Q2 2024: Soliton Announces FDA Clearance of Rapid Acoustic Pulse Device for Cellulite Reduction** Soliton, Inc. received FDA clearance for its Rapid Acoustic Pulse device, designed for the reduction in the appearance of cellulite, marking a new product entry in the U.S. medical aesthetics market.
- **Q3 2024: Alma Lasers Launches Alma TED™ Hair Restoration System in the United States** Alma Lasers announced the U.S. launch of Alma TED™, a non-invasive ultrasound-based system for hair restoration, expanding its portfolio of energy-based aesthetic devices.
- **Q3 2024: Galderma Announces U.S. Launch of Restylane® Eyelight™ for the Treatment of Undereye Hollows** Galderma launched Restylane® Eyelight™ in the U.S., a hyaluronic acid dermal filler specifically indicated for the treatment of undereye hollows.
- **Q3 2024: Sientra Files for Chapter 11 Bankruptcy Protection** Sientra, a U.S. medical aesthetics company specializing in breast implants and body contouring, filed for Chapter 11 bankruptcy protection as it seeks to restructure its operations.
- **Q4 2024: Revance Therapeutics Announces FDA Approval of DAXXIFY® for the Treatment of Cervical Dystonia** Revance Therapeutics received FDA approval for DAXXIFY® (daxibotulinumtoxinA-lanm) for the treatment of cervical dystonia, expanding its therapeutic indications in the U.S. market.
- **Q4 2024: Merz Aesthetics Launches Radiesse® (+) Lidocaine for Hand Augmentation in the U.S.** Merz Aesthetics announced the U.S. launch of Radiesse® (+) Lidocaine, a dermal filler for hand augmentation to correct volume loss in the dorsum of the hands.
- **Q1 2025: Cutera Appoints New CEO to Lead Next Phase of Growth** Cutera, a provider of energy-based aesthetic systems, appointed a new Chief Executive Officer to drive the company’s strategic growth initiatives in the U.S. medical aesthetics sector.
- **Q1 2025: Venus Concept Announces U.S. Launch of Venus Bliss Max™ for Non-Invasive Body Contouring** Venus Concept launched Venus Bliss Max™ in the U.S., a new non-invasive device for body contouring and fat reduction, expanding its product offerings in the medical aesthetics market.
- **Q2 2025: Almirall Completes Acquisition of Bonti, Expanding U.S. Aesthetics Portfolio** Almirall completed the acquisition of Bonti, a U.S.-based company focused on fast-acting neurotoxin treatments, strengthening its position in the U.S. medical aesthetics market.
- **Q2 2025: Cynosure Announces Opening of New U.S. Manufacturing Facility for Aesthetic Devices** Cynosure opened a new manufacturing facility in the United States to increase production capacity for its portfolio of energy-based aesthetic devices.

## Report Scope

| MARKET SIZE 2024 | 5.5(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 5.97(USD Billion) |
| MARKET SIZE 2035 | 13.5(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.51% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Allergan (US), Galderma (CH), Revance Therapeutics (US), Medytox (KR), Hugel (KR), Ipsen (FR), Medytox (KR), Sientra (US), Hugel (KR) |
| Segments Covered | Product, Technology, End-Use |
| Key Market Opportunities | Integration of advanced technologies in treatment procedures enhances patient outcomes and market growth potential. |
| Key Market Dynamics | Rising consumer demand for minimally invasive procedures drives innovation and competition in the medical aesthetics market. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What is the current valuation of the US medical aesthetics market?**
A: The market valuation was $5.5 Billion in 2024.

**Q: What is the projected market size for the US medical aesthetics market by 2035?**
A: The market is expected to reach $13.5 Billion by 2035.

**Q: What is the expected CAGR for the US medical aesthetics market during the forecast period 2025 - 2035?**
A: The expected CAGR is 8.51% during the forecast period.

**Q: Which segment of the US medical aesthetics market had the highest valuation in 2024?**
A: The Facial Aesthetic segment had the highest valuation at $1.65 Billion in 2024.

**Q: What is the projected valuation for the Body Contouring Devices segment by 2035?**
A: The Body Contouring Devices segment is projected to reach $2.5 Billion by 2035.

**Q: Which technology segment is anticipated to grow the fastest in the US medical aesthetics market?**
A: The Non-Invasive technology segment is likely to grow the fastest, projected to reach $7.0 Billion by 2035.

**Q: What is the expected valuation for Dermatology & Cosmetic Centers by 2035?**
A: Dermatology & Cosmetic Centers are expected to reach a valuation of $5.4 Billion by 2035.

**Q: Who are the key players in the US medical aesthetics market?**
A: Key players include Allergan, Galderma, Revance Therapeutics, and Sientra.

**Q: What is the projected growth for the Cosmetic Implants segment by 2035?**
A: The Cosmetic Implants segment is projected to grow to $2.3 Billion by 2035.

**Q: How does the market for Hair Removal Devices compare between 2024 and 2035?**
A: The Hair Removal Devices segment was valued at $0.8 Billion in 2024 and is expected to reach $1.8 Billion by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-medical-aesthetics-market-12644*